BreastfeedingSkin to Skin ContactCesarean BirthKangaroo Care
Investigational drug(s) / intervention(s)
Intervention
Intervention: Consecutive skin-to-skin contact is applied to newborns born by cesarean section, first by the father for 30 minutes immediately after birth, followed by skin-to-skin contact with the mother as soon as maternal clinical condition allows. Routine newborn care is provided alongside the intervention.
Study summary
This randomized controlled study aims to evaluate the effect of consecutive skin-to-skin contact applied by the mother and father on breastfeeding parameters and parent-infant bonding in babies born by cesarean section. The study includes two groups: an intervention group receiving consecutive skin-to-skin contact by the father followed by the mother, and a control group receiving routine postnatal care. Breastfeeding success and parental bonding will be assessed using validated measurement tools during the early postnatal period and follow-up.
Eligibility
Sex
ALL
Min age
—
Max age
—
Healthy volunteers
Accepted
Inclusion criteria:
* Mothers who delivered by cesarean section
* Mothers and fathers willing to participate and provide written informed consent
* Newborns who are stable after birth
* No health conditions in mothers or fathers that would prevent participation in skin-to-skin contact
Exclusion criteria:
* Serious maternal or neonatal illness
* Newborns requiring NICU admission
* Mothers or fathers unwilling to participate
* Any maternal or paternal condition preventing the implementation of skin-to-skin contact
Additional note:
-Eligibility is based on biological sex (female for mothers, male for fathers, newborns of any sex), not on gender identity.
Primary outcome measure(s)
Maternal Postnatal Attachment Scale (MPAS) — 3 months Maternal-infant attachment will be measured using the Maternal Postnatal Attachment Scale (MPAS). This 19-item Likert-type self-report scale assesses the mother's emotions and thoughts toward her infant.
Trial sites (1)
Facility
City
Region
Status
Zeytinburnu Avrasya Hospitol
Istanbul
Istanbul
More Istanbul University - Cerrahpasa trials in Turkey
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.